Wasawas, Nilda T.

HRN: 13-38-22  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/22/2023
03/29/2023
IV
2.25g
Q 6H
Sepsis Sec To DM Foot, L And CAP-MR
Waiting Final Action 
03/22/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/22/2023
03/29/2023
IV
600mg
Q8H
Sepsis Sec To DM Foot, L And CAP-MR
Waiting Final Action 
03/25/2023
LEVOFLOXACIN 500MG (TAB)
03/25/2023
04/01/2023
PO
750mg
OD
Infected Wound
Waiting Final Action 
04/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/15/2023
04/22/2023
IV
2.25g
Q6
Dm Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: